MTM Labs Expands Series C Round (Again)
MTM Laboratories, a German maker of in-vitro devices for early detection and diagnosis of cervical cancer, has raised €7 million in additional Series C financing. This is the second time MTM has expanded the round, bringing it up to €39 million. Gilde Healthcare Partners co-led the new tranche, and was joined by return backers HBM BioVentures, HBM BioCapital, Wellington Partners, Mannheim Holdings, Heidelberg Innovation and Nexus Medical Partners. The company's prior extension was led by Kuwait Investment Authority.
5 October 2009•3 mins read
